Executive Summary
Klein Tools has filed an IPR petition challenging all 23 claims of Milwaukee Electric Tool’s ’952 container‑assembly patent, arguing obviousness over multiple prior‑art references.
Related Cases
Shenzhen Tuozhu Technology Co., Ltd. et al.vsStratasys, Inc. et al.
The USPTO Director denied petitions for review of institution decisions in three IPRs challenging Stratasys patents, including U.S. Patent 9,421,713. The denial leaves the institution decisions standing.
Imperative Care, Inc.vsInari Medical, Inc. et al.
The PTAB denied Imperative Care's petition to institute an IPR against Inari Medical's embolism‑treatment patent, finding no reasonable likelihood of unpatentability. The petition relied on anticipation and obviousness over Garrison and other references, but lacked sufficient particularity.
SAMSUNG ELECTRONICS CO., LTD. et al.vsOMNI MEDSCI, INC.
Apple prevailed in an IPR against Omni MedSci, finding claims 7 and 10‑14 of the ’299 patent unpatentable for obviousness over Lisogurski, Carlson, Mannheimer, and Park references.
Apple Inc.vsApex Beam Technologies LLC
Apple and Apex Beam Technologies reached a confidential settlement and jointly moved to terminate the IPR over patent 10,979,128. The Board is asked to end the proceeding under 35 U.S.C. §317.
Samsung Electronics America, Inc. et al.vsTelcom Ventures LLC
The USPTO denied Samsung’s petition for rehearing of the Director’s discretionary denial in a series of IPRs against Telcom Ventures. The Board affirmed the original denial, leaving the patents in force.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.